Dr Jammi Nagaraj Rao

15 Articles Published | Follow:

As ICMR Revises COVID Guidelines, India Can Exit the Thrall of Ivermectin, HCQ

ZyCoV-D Continues India’s Habit of Approving COVID Vaccines With Invisible Data

Study Reports Covishield 63% Effective Against Delta. The Devil’s in the Details.

New Covaxin Study Makes Absence of Phase 3 Data More Conspicuous

What Message Does the Government Promoting AYUSH 64 Today Send?

What You Need To Know About the Covaxin Interim Efficacy Data

By Publicly Endorsing a Commercial Drug, Did the Health Minister Cross a Line?

How ICMR and Others Spun Covaxin’s Phase 1 Trial Results Out of Context

India Has Gained Two Vaccines but Its Regulators Have Tarnished Indian Science

Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress